81 related articles for article (PubMed ID: 20950605)
41. Role of curcumin in idiopathic pulmonary arterial hypertension treatment: a new therapeutic possibility.
Bronte E; Coppola G; Di Miceli R; Sucato V; Russo A; Novo S
Med Hypotheses; 2013 Nov; 81(5):923-6. PubMed ID: 24054817
[TBL] [Abstract][Full Text] [Related]
42. Curcumin (Diferulolylmethane) Reduces Transglutaminase 2 Overexpression Induced by Retinoic Acid in Human Nervous Cell Lines.
Gatta NG; Cammarota G; Iannaccone M; Serretiello E; Gentile V
Neuroimmunomodulation; 2016; 23(3):188-193. PubMed ID: 27780170
[TBL] [Abstract][Full Text] [Related]
43. Curcumin and autoimmune disease.
Bright JJ
Adv Exp Med Biol; 2007; 595():425-51. PubMed ID: 17569223
[TBL] [Abstract][Full Text] [Related]
44. [Abnormal Expression and Clinical Significance of B Lymphocyte Stimulating Factor in B Cell-derived Malignant Hematologic Diseases].
Han XL; Zhang XY; Li JD; Wang WL; Yang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):138-141. PubMed ID: 28245390
[TBL] [Abstract][Full Text] [Related]
45. Curcumin as a Natural Modulator of B Lymphocytes: Evidence from In Vitro and In Vivo Studies.
Mohammadi A; Mashayekhi K; Navashenaq JG; Haftcheshmeh SM
Mini Rev Med Chem; 2022; 22(18):2361-2370. PubMed ID: 35249482
[TBL] [Abstract][Full Text] [Related]
46. Curcumin-based nanotechnology approaches and therapeutics in restoration of autoimmune diseases.
Rahiman N; Markina YV; Kesharwani P; Johnston TP; Sahebkar A
J Control Release; 2022 Aug; 348():264-286. PubMed ID: 35649486
[TBL] [Abstract][Full Text] [Related]
47. Retraction: Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity.
PLOS ONE Editors
PLoS One; 2019; 14(8):e0222130. PubMed ID: 31469882
[No Abstract] [Full Text] [Related]
48. Corrigendum to "Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-
Chen J; Zhang L; Shu Y; Chen L; Zhu M; Yao S; Wang J; Wu J; Liang G; Wu H; Li W
Biomed Res Int; 2017; 2017():3236424. PubMed ID: 29445735
[TBL] [Abstract][Full Text] [Related]
49. B lymphocyte stimulator and autoimmune disease.
Wardle EN
Saudi J Kidney Dis Transpl; 2004; 15(2):155-6. PubMed ID: 17642768
[No Abstract] [Full Text] [Related]
50. Molecular insights into phytochemicals exhibiting anti-arthritic activity: systematic review : John Di Battista.
Sivasakthi P; Sanmuga Priya E; Senthamil Selvan P
Inflamm Res; 2021 Jun; 70(6):665-685. PubMed ID: 34031706
[TBL] [Abstract][Full Text] [Related]
51. Curcumin attenuates lupus nephritis in MRL/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF).
Li Q; Tan S; Xu K; Fu X; Yu J; Yang H; Wang H
Int J Clin Exp Pathol; 2019; 12(6):2075-2083. PubMed ID: 31934029
[TBL] [Abstract][Full Text] [Related]
52. Local administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal disease.
Zambrano LMG; Brandao DA; Rocha FRG; Marsiglio RP; Longo IB; Primo FL; Tedesco AC; Guimaraes-Stabili MR; Rossa Junior C
Sci Rep; 2018 Apr; 8(1):6652. PubMed ID: 29703905
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus.
Malheiros D; Panepucci RA; Roselino AM; Araújo AG; Zago MA; Petzl-Erler ML
Immunology; 2014 Nov; 143(3):381-95. PubMed ID: 24813052
[TBL] [Abstract][Full Text] [Related]
54. Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.
Park MJ; Moon SJ; Lee SH; Yang EJ; Min JK; Cho SG; Yang CW; Park SH; Kim HY; Cho ML
PLoS One; 2013; 8(6):e67171. PubMed ID: 23840617
[TBL] [Abstract][Full Text] [Related]
55. Curcumin attenuates diabetic neuropathic pain by downregulating TNF-α in a rat model.
Li Y; Zhang Y; Liu DB; Liu HY; Hou WG; Dong YS
Int J Med Sci; 2013; 10(4):377-81. PubMed ID: 23471081
[TBL] [Abstract][Full Text] [Related]
56. BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells.
Zhu J; Sun L; Lin S; Zhao R; Zhou L; Fang D; Chen L; Liu J; Shi W; Zhang L; Yuan S
J Exp Clin Cancer Res; 2012 Mar; 31(1):31. PubMed ID: 22463935
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB.
Huang G; Yang Y; Xu Z; Zhou P; Gong W; Li Y; Fan J; He F
Eur J Pharmacol; 2011 Jan; 650(1):451-7. PubMed ID: 20950605
[TBL] [Abstract][Full Text] [Related]
58. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
59. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
[TBL] [Abstract][Full Text] [Related]
60. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
